NUVASIVE INC - 21 Apr 2022 Form 3/A - Amendment Insider Report for Aclarion, Inc. (ACON)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3/A - Amendment
Accepted by SEC
23 May 2022, 16:21:26 UTC
Original report date
22 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nathaniel Sisitsky, General Counsel

Key filing fact

NUVASIVE INC filed Form 3/A - Amendment for Aclarion, Inc. (ACON) on 23 May 2022.

Key facts

  • This page summarizes NUVASIVE INC's Form 3/A - Amendment filing for Aclarion, Inc. (ACON).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 23 May 2022, 16:21.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACON holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,126,495
Date
21 Apr 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 3 is being amended to correct the amount of securities beneficially owned.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .